ArticleJournal of cellular and molecular medicine2022

Clinical and prognostic implications of an immune-related risk model based on TP53 status in lung adenocarcinoma.

Xuming Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.